Humans are living longer than ever. But age-related diseases such as sarcopenia - the loss of muscle mass - are on the rise. Researchers in Basel say a well-known drug might help delay the aging process.
The Swiss generally live long lives. According to the most recent statistics, Swiss men live on average to the age of 81.3, and women to 85.3. But as a natural part of aging, over time people’s muscles lose tone, shrink and strength dwindles.
This condition, known as sarcopenia, affects every second or third person over 80, reducing their mobility, autonomy and quality of life. The causes of sarcopenia are diverse: from altered muscle metabolism to changes in nerves supplying muscles.
A group of scientists at the University of Basel’s BiozentrumExternal link, which has been investigating the question, has identified a key molecular ‘signature’ of sarcopenia. The team, led by Professor Markus Rüegg, have discovered that mTORC1, which acts as a sensor and controls protein synthesis in the body, also contributes to sarcopenia and its suppression with the well-known drug rapamycin slows age-related muscle wasting.
“Contrary to our expectations, the long-term mTORC1 suppression with rapamycin is overwhelmingly beneficial for skeletal muscle aging in mice, preserving muscle size and strength,” declared Daniel Ham, first author of the study.
To encourage other scientists to further investigate how gene expression in skeletal muscle changes during aging or in response to rapamycin treatment, they have created a web application, SarcoAtlasExternal link, which is supported the Centre for Scientific Computing at the University of Basel (sciCORE).
Currently, there is no effective pharmacological therapy to treat sarcopenia. But the scientists say their study gives hope that in the future it may be possible to slow down age-related muscle wasting with treatments that suppress mTORC1 and thereby extend the autonomy and life quality of elderly people.
Popular Stories
More
Climate adaptation
Why Switzerland is among the ten fastest-warming countries in the world
Train vs plane: would you take a direct train between London and Geneva?
Eurostar is planning to run direct trains from Britain to Germany and Switzerland from the early 2030s. Would you favour the train over the plane? If not, why not?
This content was published on
Swiss companies are increasingly being targeted by cyber criminals. In the past quarter, every single company in this country was the target of a cyber attack an average of 1097 times a week.
Swiss households faced 21 minutes of power outages in 2024
This content was published on
End customers experienced an average of 21 minutes of electricity interruption in 2024. This resulted in 0.34 power outages per capita. The duration of electricity interruptions increased by three minutes compared to the previous year.
Swiss citizens will be voting on restricting wind farm expansion
This content was published on
On Friday, the Association for the Protection of Nature and Democracy submitted two initiatives aimed at curbing the expansion of wind farms. More than 110,000 signatures have been collected.
E-bike riders regularly break speed limit in residential areas
This content was published on
Fast e-bikes regularly exceed the speed limit in residential areas. According to a new study with data on cyclists in Zurich, they regularly reach speeds of over 30 km/h.
This content was published on
Swiss small and medium-sized enterprises (SMEs) are struggling to find staff, a problem made more acute by the increased bargaining power of employees and increased absenteeism.
Switzerland very close to tariff deal with the US, says Roche CEO
This content was published on
An understanding between Berne and Washington in the dispute over customs barriers is close: Roche CEO Thomas Schinecker is convinced of this.
This content was published on
Late on Thursday in Geneva, pro-Palestinian demonstrators attacked the Permanent Mission of Israel to the United Nations in the international organisations district. They poured red paint over the entrance to the building.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Heart disease and cancer still biggest causes of death
This content was published on
Cardiovascular disease and cancer were the two most widespread causes of death in Switzerland in 2017, new statistics have shown.
This content was published on
The latest federal health survey of people 55 and older reveals that social factors such as education influence health into old age.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.